MECP2 duplication syndrome

Protein MECP2 PDB 1qk9

MECP2 duplication syndrome is a rare genetic disorder characterized by the duplication of the MECP2 gene located on the X chromosome. This condition primarily affects males, as they have only one X chromosome, while females have two X chromosomes, which can mitigate the effects of the duplication.

Genetics

The MECP2 gene provides instructions for making a protein called methyl-CpG-binding protein 2, which is involved in the regulation of other genes. The duplication of the MECP2 gene leads to an overproduction of this protein, disrupting normal gene regulation and causing the symptoms associated with the syndrome.

Symptoms

Individuals with MECP2 duplication syndrome often exhibit a range of symptoms, including:

• Intellectual disability
• Developmental delay
• Seizures
• Hypotonia (low muscle tone)
• Recurrent respiratory infections
• Gastrointestinal issues

Diagnosis

Diagnosis of MECP2 duplication syndrome typically involves genetic testing, such as chromosomal microarray analysis or fluorescence in situ hybridization (FISH), to detect the duplication of the MECP2 gene.

Treatment

There is currently no cure for MECP2 duplication syndrome. Treatment focuses on managing symptoms and may include:

• Antiepileptic drugs for seizures
• Physical therapy for hypotonia
• Speech therapy for communication difficulties
• Occupational therapy to improve daily living skills

Prognosis

The prognosis for individuals with MECP2 duplication syndrome varies. While some individuals may have a relatively mild form of the disorder, others may experience severe symptoms that significantly impact their quality of life.

Related Pages

• MECP2
• X chromosome
• Genetic disorder
• Intellectual disability
• Seizures
• Hypotonia